See what your fund actually adds
Fidelity Disruptive Medicine ETF FMED
Historical return decomposition and an investable replication portfolio, using data through 2026-10-09.
Fund and replication metrics
| Measure | FMED | Replication |
|---|---|---|
| Annualized growth | 9.0% | 13.3% |
| Annualized volatility | 19.3% | 13.8% |
| Sharpe ratio | 0.54 | 0.97 |
| Maximum drawdown | 17.6% | 13.4% |
| Replication fit (R²) | 0.68 · Tracking error 10.9% | |
Replication portfolio
The published portfolio below is the investable basket used to model FMED’s historical return behavior.
| Ticker | Building block | Weight |
|---|---|---|
| XLV | Sector · Healthcare | 61.0% |
| IWC | Micro Cap | 18.3% |
| VOX | Sector · Communication | 14.7% |
| XLK | Sector · Technology | 3.3% |
| VBK | Small-Cap · Growth | 2.7% |